137 related articles for article (PubMed ID: 7738640)
1. Technetium-99m-methylene diphosphonate scintimammography to image primary breast cancer.
Piccolo S; Lastoria S; Mainolfi C; Muto P; Bazzicalupo L; Salvatore M
J Nucl Med; 1995 May; 36(5):718-24. PubMed ID: 7738640
[TBL] [Abstract][Full Text] [Related]
2. Scintimammography with 99mTc-MDP in the detection of primary breast cancer.
Piccolo S; Lastoria S; Muto P; Bazzicalupo L; Bartiromo A; Salvatore M
Q J Nucl Med; 1997 Sep; 41(3):225-30. PubMed ID: 9274130
[TBL] [Abstract][Full Text] [Related]
3. Technetium-99m methylene diphosphonate scintimammography for evaluation of palpable breast masses.
Lee JK; Kao CH; Sun SS
Oncol Rep; 1999; 6(3):659-63. PubMed ID: 10203611
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m MDP scintimammography in palpable and nonpalpable breast lesions: comparison with mammographic probability of malignancy.
Atasever T; Ozdemir A; Turkölmez S; Altinok M; Isik S
Anticancer Res; 1999; 19(4C):3601-6. PubMed ID: 10629658
[TBL] [Abstract][Full Text] [Related]
5. 99mTc-MIBI and 99mTc-MDP scintimammography for detecting breast carcinoma.
Chen S; Liu W; Mao Y; Zhu W; Yao Z; Sun X; Xiu Y; Yin Y; Chen J
Chin Med J (Engl); 2000 May; 113(5):400-3. PubMed ID: 11776092
[TBL] [Abstract][Full Text] [Related]
6. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
7. 99m-Tc-MDP-Scintimammography in the evaluation of breast masses or tumor angiogenesis.
Turhal NS; Dane F; Dede F; Gumus M; Yumuk PF; Cakalagaoglu F; Savci D; Karaman M; Gulluoglu B; Turoglu HT
Anticancer Res; 2004; 24(3b):1999-2006. PubMed ID: 15274391
[TBL] [Abstract][Full Text] [Related]
8. Acquisition protocol for breast cancer imaging with technetium-99m-labeled synthetic peptide and technetium-99m-MDP.
Fiorenza M; Prisco G; Bartolomei M; Chinol M; Cremonesi M; Leonardi L; De Cicco C; Paganelli G
J Nucl Med Technol; 1997 Sep; 25(3):191-4. PubMed ID: 9291065
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic value of 99mTc-methoxy-isobutyl-isonitril and 99mTc-methylene diphosphonate scintimammography in the preoperative evaluation of breast cancer].
Schmidt E; Kett K; Anga B; Bódis J; Zámbó K
Orv Hetil; 2003 Apr; 144(17):787-92. PubMed ID: 12762063
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
11. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
12. Occult breast cancer: scintimammography with high-resolution breast-specific gamma camera in women at high risk for breast cancer.
Brem RF; Rapelyea JA; Zisman G; Mohtashemi K; Raub J; Teal CB; Majewski S; Welch BL
Radiology; 2005 Oct; 237(1):274-80. PubMed ID: 16126919
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions.
Massardo T; Alonso O; Kabasakal L; Llamas-Olier A; Shankar UR; Zhu H; Delgado L; González P; Mut F; Padhy AK
J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457
[TBL] [Abstract][Full Text] [Related]
14. 99mTc sestamibi scintimammography. Screening mammographic non-palpable suspicious breast lesions: preliminary results.
Bekiş R; Derebek E; Balci P; Koçdor MA; Değirmenci B; Canda T; Durak H
Nuklearmedizin; 2004 Feb; 43(1):16-20. PubMed ID: 14978536
[TBL] [Abstract][Full Text] [Related]
15. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
16. Scintimammography with 99mTc-MDP: experience of the National Cancer Institute of Naples.
Piccolo S; Lastoria S; Thomas R; Muto P; Apicella A; Petrosino T; Cortino G; D'Aiuto G; Ziviello M
Eur J Radiol; 1998 May; 27 Suppl 2():S275-81. PubMed ID: 9652535
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m tetrofosmin scintigraphy to evaluate breast lesions.
Madariaga P; Almoguera I; Alonso A; Escat JL; Vegazo O; Martinez ML; Trampal C; Perez Vazquez JM
Anticancer Res; 1997; 17(3B):1619-21. PubMed ID: 9179205
[TBL] [Abstract][Full Text] [Related]
18. Intense uptake of technetium-99m-MDP in primary breast adenocarcinoma with sarcomatoid metaplasia.
Pickhardt PJ; McDermott M
J Nucl Med; 1997 Apr; 38(4):528-30. PubMed ID: 9098196
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-methylene diphosphonate scintimammography in male breast cancer.
Inanir S; Kiliç AK; Ozdemir E; Zorlutuna Y
J Nucl Med; 1998 Jan; 39(1):28-9. PubMed ID: 9443733
[TBL] [Abstract][Full Text] [Related]
20. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
